Ductal carcinoma in situ
Ductal carcinoma in situ (DCIS) is a non-invasive form of breast cancer where abnormal cells have been found in the lining of the breast milk duct. The atypical cells have not spread outside of the ducts into the surrounding breast tissue. Ductal Carcinoma In Situ is very early cancer that is highly treatable, but if it’s left untreated or undetected, it can spread into the surrounding breast tissue.
Symptoms[edit | edit source]
DCIS itself does not cause symptoms. It is often detected during a mammogram as part of a regular screening program.
Causes[edit | edit source]
The exact cause of DCIS is unknown. However, it is known that cancer arises when a cell's DNA is damaged. Factors that may increase your risk of DCIS include age, a personal history of benign (noncancerous) breast disease, a family history of breast cancer, inherited genes that increase the risk of breast cancer, radiation exposure, and hormone therapy.
Diagnosis[edit | edit source]
DCIS is usually found during a mammogram done as part of a routine screening program. If an abnormal area is seen on the mammogram, a biopsy may be done to check for cancer cells.
Treatment[edit | edit source]
Treatment options for DCIS include lumpectomy in combination with radiation therapy, mastectomy, and hormone therapy.
Prognosis[edit | edit source]
The prognosis for DCIS is generally very good. Since DCIS is a non-invasive cancer, it is highly treatable. However, it is important to have regular check-ups after treatment to ensure that the cancer has not returned or spread.
See also[edit | edit source]
References[edit | edit source]
 | |
|---|---|
 |
 |
Lobules and ducts of the breast
Breast DCIS histopathology
Diagram showing ductal carcinoma in situ (DCIS)
Ductal carcinoma in situ
Mammogram microcalcifications in carcinoma in situ
Histopathology of dystrophic microcalcifications in ductal carcinoma in situ
Histopathologic architectural patterns of DCIS
Histopathology of high-grade DCIS
Histopathology of microinvasive ductal carcinoma in situ
Immunohistochemistry with calponin in ductal carcinoma in situ
Histopathology of ductal carcinoma in situ with comedo necrosis
Pie chart of incidence and prognosis of histopathologic breast cancer types
.jpg)
_CRUK_115.svg)
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
